VistaGen Therapeutics Reports Third Quarter Fiscal 2018 Financial Results - Markets Insider

Submitted by Anonymous (not verified) on Mon, 02/12/2018 - 21:36

VistaGen Therapeutics Reports Third Quarter Fiscal 2018 Financial ResultsMarkets Insider"Building on our significant progress last quarter, our team is prepared and eager to launch, during the current quarter, our AV-101 Phase 2 clinical development program, initially focused on adjunctive treatment of Major Depressive Disorder patients ...and more »